TerraBioGen Announces Private Placement
24 Mai 2011 - 5:46PM
Marketwired
TerraBioGen Technologies Inc. (TSX VENTURE: TBG), a developer and
marketer of proprietary technologies for the production of
organic-based, high-value agricultural products from organic
wastes, announces that it intends to issue, by way of a
non-brokered private placement, 10,000,000 units at a price of
$0.10 per share for gross proceeds of $1,000,000. Each unit
consists of one common share and one-half warrant; each full
warrant may be used to purchase shares at $0.15 for eighteen
months.
The proceeds of the financing will be used for operating
expenses, production improvements, and to enhance the Company's
research and development, and intellectual property. The private
placement is subject to the approval of the TSX Venture
Exchange.
About TerraBioGen
Located in North Vancouver, BC, TerraBioGen Technologies Inc. is
committed to research and development to continue to improve the
efficiency of its technology and the quality of its agricultural
products. It is further committed to developing a world-wide
marketing capability to ensure market acceptance of its
products.
This news release contains certain statements that may be deemed
"forward-looking" statements. Forward looking statements are
statements that are not historical facts and are generally, but not
always, identified by the words "expects", "plans", "anticipates",
"believes", "intends", "estimates", "projects", "potential" and
similar expressions, or that events or conditions "will", "would",
"may", "could" or "should" occur. Although TerraBioGen believes the
expectations expressed in such forward-looking statements are based
on reasonable assumptions, such statements are not guarantees of
future performance and actual results may differ materially from
those in forward looking statements. Forward looking statements are
based on the beliefs, estimates and opinions of TerraBioGen's
management on the date the statements are made. Except as required
by law, TerraBioGen undertakes no obligation to update these
forward-looking statements in the event that management's beliefs,
estimates or opinions, or other factors, should change.
THIS PRESS RELEASE, REQUIRED BY APPLICABLE CANADIAN LAWS, IS NOT
FOR DISTRIBUTION TO U.S. NEWS SERVICES OR FOR DISSEMINATION IN THE
UNITED STATES, AND DOES NOT CONSTITUTE AN OFFER OF THE SECURITIES
DESCRIBED HEREIN. THESE SECURITIES HAVE NOT BEEN REGISTERED UNDER
THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED, OR ANY STATE
SECURITIES LAWS, AND MAY NOT BE OFFERED OR SOLD IN THE UNITED
STATES OR TO U.S. PERSONS UNLESS REGISTERED OR EXEMPT
THEREFROM.
Neither the TSX Venture Exchange nor its Regulation Services
Provider (as that term is defined in policies of the TSX Venture
Exchange) accepts responsibility for the adequacy or accuracy of
this release.
Contacts: TerraBioGen Technologies Inc. Blair Heffelfinger
President & CEO (604) 924-1023 ext 316 (604) 924-1043 (FAX)
bheffelfinger@terrabiogen.com TerraBioGen Technologies Inc. Bob
Nowell CFO & Corporate Secretary (604) 924-1023 ext 306 (604)
924-1043 (FAX) bnowell@terrabiogen.com www.terrabiogen.com
Terrabiogen Technologies (TSXV:TBG)
Historical Stock Chart
Von Mai 2024 bis Jun 2024
Terrabiogen Technologies (TSXV:TBG)
Historical Stock Chart
Von Jun 2023 bis Jun 2024